Niva Bupa Health Insurance Company Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 35.66% vs 2.22% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 493.80% vs -148.48% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 487.68% vs -77.05% in Dec 2025

Interest

No Interest in the last few periods

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Niva Bupa Health With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

1,971.95

9,968.57

-7,996.62

-80.22%

Other Operating Income

166.61

2,519.03

-2,352.42

-93.39%

Total Operating income

2,138.56

12,487.60

-10,349.04

-82.87%

Raw Material Cost

0.00

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

154.65

989.42

-834.77

-84.37%

Power Cost

0.00

Manufacturing Expenses

1,488.77

10,509.23

-9,020.46

-85.83%

Selling and Distribution Expenses

20.56

0.00

20.56

Other Expenses

109.35

978.12

-868.77

-88.82%

Total Expenditure (Excl Depreciation)

1,773.33

12,476.77

-10,703.44

-85.79%

Operating Profit (PBDIT) excl Other Income

365.23

10.83

354.40

3,272.39%

Other Income

-24.07

426.22

-450.29

-105.65%

Operating Profit (PBDIT)

341.16

437.05

-95.89

-21.94%

Interest

0.00

Exceptional Items

0.00

Gross Profit (PBDT)

341.16

437.05

-95.89

-21.94%

Depreciation

0.00

Profit Before Tax

341.16

437.05

-95.89

-21.94%

Tax

-3.97

-120.69

116.72

96.71%

Provisions and contingencies

0.00

Profit After Tax

345.13

557.74

-212.61

-38.12%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

345.13

557.74

-212.61

-38.12%

Equity Capital

1,847.46

824.00

1,023.46

124.21%

Face Value

10.00

5.00

0.00

Reserves

1,371.51

22,795.27

-21,423.76

-93.98%

Earnings per share (EPS)

1.87

3.38

-1.51

-44.67%

Diluted Earnings per share

1.86

3.38

-1.52

-44.97%

Operating Profit Margin (Excl OI)

18.52%

0.11%

0.00

18.41%

Gross Profit Margin

17.30%

4.38%

0.00

12.92%

PAT Margin

17.50%

5.59%

0.00

11.91%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,971.95 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 35.66% vs 2.22% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 29.10% vs 25.40% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 345.13 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 493.80% vs -148.48% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 67.47% vs 31.21% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 365.23 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 487.68% vs -77.05% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 45.71% vs 149.54% in Mar 2025

Quarterly - Interest

No Interest in the last few periods

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.52%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025